4,4,5,5-Tetramethyl-2-(5-methyl-1-cyclohexen-1-yl)-1,3,2-dioxaborolane is a reagent that is used in the preparation of azaindole derivatives as c-Jun N-terminal kinase inhibitors. These inhibitors are useful in the treatment of neurodegenerative disorders, inflammatory diseases and autoimmune diseases.
